Meet-the-Professor Session:
19. Shall We Agree to Disagree: Management of Pediatric Acute Hematogenous Osteomyelitis
Thursday, October 4, 2018: 7:15 AM-8:15 AM
Room: W 2014-2016

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • explain the transition to oral antimicrobial therapy: What should the criteria be and are the criteria different for bacteremic patients?
  • discuss data for oral antimicrobial dosing: Choice of agent, Dosing intervals
  • review intravenous therapy for bacteremic patients with MSSA
  • describe the utility/yield and timing of bone aspirates for culture
  • explain the use of inflammatory markers to guide management and therapy

Target Audience: Academicians, Clinicians, Fellows, Healthcare workers, Infectious diseases pediatricians, Infectious diseases physicians, Medical students and residents, Members-in-training, Nurses, Pharmacists

Tracks: Trainee, Pediatric ID


CME Credits: Maximum of 1.00 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-18-186-L01-P


Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.